Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line
about
Comparative genomic analysis of equilibrative nucleoside transporters suggests conserved protein structure despite limited sequence identity.Plasma membrane transporters in modern liver pharmacologyTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Nucleoside transporter proteins of Saccharomyces cerevisiae. Demonstration of a transporter (FUI1) with high uridine selectivity in plasma membranes and a transporter (FUN26) with broad nucleoside selectivity in intracellular membranes.Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparumTransport of nucleosides across the Plasmodium falciparum parasite plasma membrane has characteristics of PfENT1Blood brain barrier: a challenge for effectual therapy of brain tumorsFunctional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocationMolecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brainIdentification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitorsExtracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transportersMolecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridineDifferential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cellsIdentification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2Equilibrative nucleoside transporters-A review.Adenosine and hemodialysis in humans.The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in miceXenobiotic, bile acid, and cholesterol transporters: function and regulation.ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes.Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs.The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms.Comparison of mouse and human genomes followed by experimental verification yields an estimated 1,019 additional genes.Implication of the purinergic system in alcohol use disorders.Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes.Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders.Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.Nucleoside transporters in chronic lymphocytic leukaemia.The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters.Regulation of equilibrative nucleoside uptake by protein kinase inhibitors.Renal nucleoside transporters: physiological and clinical implications.Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.The role of transporters in the toxicity of nucleoside and nucleotide analogs.The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity.Physiology of nucleoside transporters: back to the future. . . .Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).Human nucleoside transporters: biomarkers for response to nucleoside drugs.Drug transporter pharmacogenetics in nucleoside-based therapies.
P2860
Q24537625-02FF3E70-CD39-4AB7-AD30-1B453A646E59Q26829263-79423685-742A-48E5-97E4-CD8509AAA011Q27690256-07B87277-29AE-4D46-8E8C-29E15CF26E24Q27934663-7DCAAAEB-8D02-486A-9056-F704EB9AFD64Q27973843-6A89C860-3122-4DA9-B044-5E30C5EE2600Q27973849-79326050-DBF2-4B6E-A096-0C0F68FB77B8Q28081947-8E198423-52E1-41A5-B09C-9177CDA5C4F9Q28217218-E59548BF-33C2-49E6-B5C1-598572A12F11Q28344960-5E273B0F-E06D-4781-AABE-154DD2A7246DQ28345550-5AA032FF-9A49-4EBE-AE74-81E0240BF5E4Q28362731-C25BCB97-AB50-4A36-9DF9-98FBBAC324E9Q28365707-5877CA16-77FE-40F3-98EF-01AFC9F87078Q28372006-9748A946-8252-487F-83ED-00B0329381E0Q28377219-D4B7C17A-E359-40D3-A275-0C6E86BB75A4Q28570384-0BD3CA5D-5901-4610-8348-615E107CF2C3Q28610373-A18BF690-E85F-469C-BA1D-1936239C1F5EQ30244329-A6025399-D334-4575-A1BA-EB8E38C8D364Q32056614-EA64B3AD-778B-42B6-91F7-36490B6CF8F8Q33699976-908DDF7D-6E2F-4E22-ABEB-30E411FAC91CQ33714593-068A9044-585A-4D7B-B794-F272BBBEF93DQ34035612-3A7D45BE-2DA2-49B4-8DBD-3679B4227FF8Q34093436-8D2D6BFA-0FC4-4477-BC93-7E4F15F48808Q34276389-3ECB5053-8744-47A6-B0E6-CBD481E49DE5Q34329481-CB006C1C-C525-4944-987D-CAEFB6549C78Q34789609-8246A49D-AD7A-4431-9388-DE1964C0BE70Q35003182-B8D9319D-CFFB-4B05-822D-4572A9EF62CDQ35206509-D8629A46-5E54-4CAB-8694-52F81B88CE0CQ35213302-59964F96-EB30-4C63-9513-06CEB0E7C7FEQ35567292-752D8674-0245-4DD5-A2EA-3CD5F110FE59Q35635321-1FC7366E-5C48-4FDF-A584-1CBDFBD99CB6Q35788344-0E8803DF-AADA-4B6D-8E53-5936BF66ECD2Q35967219-041AEF95-5BD4-474B-A775-47FFF21549B5Q36704491-426C30EA-BB3B-4EAE-8959-D49AE0F4173CQ36709135-7D212D8B-3DF3-4E75-9683-8E010F7A9986Q36921993-A5ABF544-AC6E-4E4B-B2C7-839D3700886DQ36960546-7A02679D-E18A-441B-89B5-3E5FBA8084F2Q37082372-054364C7-0CC9-4B30-811E-199F403C3A6AQ37399109-9ECC82CF-65A8-4E07-88E7-E1E615DC183EQ37698437-44D2245E-55A2-4BF8-B680-2A5C08008DA4Q37760954-8ED37BC2-0B3C-4A86-B593-2F588FD33047
P2860
Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Cloning of the human equilibra ...... transport-deficient cell line
@ast
Cloning of the human equilibra ...... transport-deficient cell line
@en
Cloning of the human equilibra ...... transport-deficient cell line
@nl
type
label
Cloning of the human equilibra ...... transport-deficient cell line
@ast
Cloning of the human equilibra ...... transport-deficient cell line
@en
Cloning of the human equilibra ...... transport-deficient cell line
@nl
prefLabel
Cloning of the human equilibra ...... transport-deficient cell line
@ast
Cloning of the human equilibra ...... transport-deficient cell line
@en
Cloning of the human equilibra ...... transport-deficient cell line
@nl
P2093
P2860
P356
P1476
Cloning of the human equilibra ...... transport-deficient cell line
@en
P2093
P2860
P304
P356
10.1074/JBC.273.9.5288
P407
P577
1998-02-27T00:00:00Z